Randomized Controlled Trial
Copyright ©The Author(s) 2020.
World J Hepatol. Nov 27, 2020; 12(11): 1098-1114
Published online Nov 27, 2020. doi: 10.4254/wjh.v12.i11.1098
Table 3 Matrix metalloproteinases and tissue inhibitors of metalloproteinases in the different groups

Groups

P (95%CI)
MMP2 Desflurane80.6 ± 42.3a(-46.4 to 3.1)
Control123.5 ± 51.7
MMP9 Desflurane178.5 ± 80.3b(-473.9 to 203.1)
Control449.9 ± 298.8
TIMP1 Desflurane173.3 ± 87.6b(25.9 to 104.3)
Control104.4 ± 39.7
TIMP2 Desflurane154.4 ± 65.4b(35.7 to 93.6)
Control90.6 ± 29.3